Perspective Therapeutics appoints Heidi Henson to board as Audit Committee Chair; McCormick resigns

Perspective Therapeutics, Inc.

Michael McCormick resigned from the Board effective immediately; departure described as amicable.
Heidi Henson appointed as director effective June 1, 2023, to fill the vacancy; named Audit Committee Chair.
Rob Williamson steps down as Audit Committee Chair but remains a member; becomes Compensation Committee Chair.
Lori Woods steps down as Compensation Committee Chair but remains a member.
Henson has over 25 years of finance experience, most recently CFO of Pardes Biosciences.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Heidi Henson

Director

CATX · Perspective Therapeutics, Inc.

Effective: 2023-06-01
Filed: May 15, 2023, 7:59 PM ET

Following Mr. McCormick’s resignation, effective as of June 1, 2023, the Board appointed Ms. Heidi Henson as a director of the Company to fill the vacant position on the Board and a member of the Audit (as Chairperson) and Compensation committees of the Board.

Departed

Michael McCormick

Director

CATX · Perspective Therapeutics, Inc.

Effective: 2023-05-09
Successor: Heidi Henson
Filed: May 15, 2023, 7:59 PM ET

On May 9, 2023, Michael McCormick gave notice of his resignation from the Board of Directors of the Company (the “ Board ”), effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Heidi Henson was appointed as Director at Perspective Therapeutics, Inc..

Action: appointed
Role: Director

Exact text from the filing

Following Mr. McCormick’s resignation, effective as of June 1, 2023, the Board appointed Ms. Heidi Henson as a director of the Company to fill the vacant position on the Board and a member of the Audit (as Chairperson) and Compensation committees of the Board.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael McCormick resigned as Director at Perspective Therapeutics, Inc..

Action: resigned
Role: Director

Exact text from the filing

On May 9, 2023, Michael McCormick gave notice of his resignation from the Board of Directors of the Company (the “ Board ”), effective immediately.

View on SEC.gov

Perspective Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-23-014648

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.